Differences of sympathomimetic and anticholinergic action of OH-maprotiline and its R (-)-enantiomer.

1 C 49802 B-Ba and CGP 12103/A are the racemate and the R (-)-enantiomer respectively of the hydroxylated derivative of the tetracyclic antidepressant maprotiline, which differed in their ability to block noradrenaline-uptake and in their anticholinergic activity in animal models. 2 The sympathomimetic and anticholinergic activities of both substances were evaluated in eight healthy subjects and compared with the treatment with placebo and amitriptyline. 3 Heart rate, pupillary diameter, stimulated salivary flow rate and blood pressure were measured over a 15 h period keeping a very strict protocol. Plasma catecholamine levels were determined. 4 Saliva production was diminished following the administration of C 49802 B-Ba, CGP 12103/A and amitriptyline. 5 A moderate, but significant increase in heart rate and mean arterial blood pressure in the recumbent position was observed when C 49802 B-Ba was given. 6 The results in man are in agreement with the different activities found in animal experiments. 7 It can be concluded that the S (+)-enantiomer which the racemate contains is more active than the R (-)-enantiomer as to the anticholinergic and the sympathomimetic property.

[1]  C. Bradshaw,et al.  The Peripheral Anticholinergic Activity of Tricyclic Antidepressants: Comparison of Amitriptyline and Desipramine in Human Volunteers , 1980, British Journal of Psychiatry.

[2]  P. Turner Tests of autonomic function in assessing centrally-acting drugs. , 1980, British journal of clinical pharmacology.

[3]  P. Waldmeier,et al.  AMINE UPTAKE INHIBITORS: CRITERIA OF SELECTIVITY , 1980, Acta psychiatrica Scandinavica.

[4]  H. Kopera Anticholinergic and blood pressure effects of mianserin, amitriptyline and placebo. , 1978, British journal of clinical pharmacology.

[5]  C. Burgess,et al.  Cardiovascular responses to mianserin hydrochloride: a comparison with tricyclic antidepressant drugs. , 1978, British journal of clinical pharmacology.

[6]  E. Raeder,et al.  Cardiovascular effects of tricyclic and tetracyclic antidepressants. , 1978, JAMA.

[7]  P. Waldmeier,et al.  Selective inhibition of noradrenaline and serotonin uptake by C 49802-B-Ba and CGP 6085 A. , 1977, European journal of pharmacology.

[8]  M. da Prada,et al.  Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range. , 1976, Life sciences.

[9]  J. Jefferson A Review of the Cardiovascular Effects and Toxicity of Tricyclic Antidepressants , 1975, Psychosomatic medicine.

[10]  S. Siegel,et al.  Nonparametric Statistics for the Behavioral Sciences , 2022, The SAGE Encyclopedia of Research Design.

[11]  M. Lader,et al.  Physiological and Psychological Effects of Antidepressants in Man , 1980 .

[12]  C. J. Jones,et al.  Evaluation of the anticholinergic actions of glycopyrronium bromide. , 1978, British journal of clinical pharmacology.